Introduction
Transcranial direct current stimulation (tDCS) is a noninvasive therapy that uses a direct current electrical field (DCEF) to modulate neuronal activity (Nitsche et al., 2008; Bikson et al., 2009; Kabakov et al., 2012) , which can have beneficial effects for months following its delivery (Benninger et al., 2010) . There are 2 ways to deliver DCEF to the brain: via anodal or cathodal stimulation. Anodal tDCS usually induces an increase in cortical excitability, whereas cathodal tDCS provokes the opposite effect (Nitsche et al., 2008) .
The method of tDCS has been trialed for a variety of neurological and psychiatric disorders, including major depression (Dell'osso et al., 2013) , epilepsy (Auvichayapat et al., 2013) , stroke (Joung Lee and Chun, 2013) , and Parkinson's disease (Boggio et al., 2006; Benninger et al., 2010; Pereira et al., 2013) . In addition, DCEF delivered via electrodes surgically placed into the spine has been safely used in patients with complete spinal lesions with significant motor and sensory improvements (Shapiro et al., 2005) .
Recent animal studies, although still very few in number, have been instrumental in identifying a number of potential mechanisms by which tDCS could produce these beneficial clinical effects. In vivo studies in rodents have provided evidence that tDCS is not only neuromodulatory but can also exert neuroprotective effects as demonstrated in epilepsy and ischemia models (Kim et al., 2010; Kamida et al., 2011) . More specifically, it has been shown that tDCS can increase growth cone development (Yoon et al., 2012; Auvichayapat et al., 2013) , promote neurogenesis (Rueger et al., 2012) , and modulate inflammatory responses (Jiang et al., 2012; Rueger et al., 2012; PeruzzottiJametti et al., 2013) . Moreover, in animals with spinal cord injury, the therapy can induce axonal regeneration across scar tissues along with reducing scar tissue size (Borgens, 1999) .
In addition to these encouraging results, tDCS offers several advantages over more invasive treatments such as deep brain stimulation (DBS), cell replacement, or gene therapies. First of all, tDCS has proven to be safe, well-tolerated and is inexpensive. Secondly, the size of the device and the simplicity of its mode of action make it easy for patients to use themselves. Nevertheless, although a promising therapy, the mechanisms of action are still unclear, so we set about looking at this with respect to the different cells of the central nervous system. This involved stimulating a range of cell lines in vitro, including N2a (neuronal-like cells), BV2 (microglia), and C8-D1A (astrocytes) cells as well as explants derived from the mouse ventral tegmental area (VTA) using a DCEF stimulation prototype that we developed specifically for these experiments. Here, we report on the viability and morphological and molecular changes seen in these different cells exposed to various DCEFs.
Materials and Methods

Electrotactic Chamber and DCEF Application
The design of the electrotactic chamber was based on previously described methodology (Song et al., 2007; Koppes et al., 2011) ( Figure 1A -B). Polydimethylsiloxane (PDMS; Sylgard 184, Dow Corning, Midland, MI) was added to a microscope cover glass into a 100 × 20-mm tissue culture petri dish (Starstedt, Montreal, QC, Canada) . The cover glass was removed and the PDMS cut to create a 50 × 24 × 0.2-mm chamber (an area of 12 cm 2 for cell seeding) that was placed in a new 100 × 20-mm tissue culture petri dish. Small reservoirs on each side of the chamber were delineated using a commercial silicone preparation (3140 MIL-A-46146 RTV Coating, Dow Corning) to help stabilize pH (Song et al., 2007) and to allow direct current flow exclusively within the chamber (Babona-Pilipos et al., 2012) . Cells were seeded within the electrotactic chamber ( Figure 1A -B). The reservoirs were connected to a central petri dish by agar bridges composed of glass tubes filled with sterile 1% agarose (J.T. Baker, Mansfield, MA) diluted in Dulbecco's Modified Eagle Medium (DMEM, Sigma-Aldrich, Oakville, ON, Canada). The side petri dishes housing the electrodes were also filled with sufficient volumes of DMEM and, if needed, additional media was added to ensure an adequate buffer zone. The electrodes were made of silver chloride (AgCl) wires (Pico Wire, Etobicoke, ON, Canada), of which the tip was stripped. They were connected to a current regulator, which was in turn connected to a direct current (DC) power supply delivering field strengths of 25, 50, or 100 V/m ( Figure 1C ). This configuration allowed us to physically isolate the cells from pH variations and metallic wastes generated by the electrodes. The strength of the DCEF was measured at the extremities of the chamber using a multimeter recording device at 4, 8, and 24 hours of stimulation. Temperature (thermocouple device; Omega, Laval, QC, Canada) and pH (pH meter; Oakton, Vernon Hills, IL) of the culture medium for each cell type were closely monitored during a 24-hour stimulation period to ensure that observations collected were not due to changes in these parameters.
For explant cultures, tissues were stimulated with a slightly different methodology, using an approach in which the electrotactic chamber resembled that used by Cork et al. (1994) . To create the electrotactic chamber, the explants, coated in a 3D matrix gel onto a 12-mm coverslip, were placed upside down between 1-mm-thick glass slides adjusted with a rotary tool (Dremel, Mississauga, ON, Canada). They were fixed with a commercial silicone preparation (3140 MIL-A-46146 RTV Coating, Dow Corning) 4 mm apart in the middle well of a 6-well plate (Starstedt) forming a 5 mm × 4 mm × 1 mm chamber (0.2 cm 2 ). The remaining procedure was as described for cell culture except that the reservoirs contained Neurobasal Medium (Invitrogen) instead of DMEM.
Cell Culture
Murine N2a neuroblastoma (ATCC, Burlington, ON, Canada), BV2 microglial (gift from Dr. Serge Rivest, CRCHUQ), and C8-D1A astrocytic cells (ATCC) were seeded at densities of 1.36 × 10 4 cells/ cm 2 for N2a and BV2 cells and 3.64 × 10 4 cells/cm 2 for C8-D1A cells, taking into account cell division rates of each cell type. Cells were maintained in DMEM (D5796, Sigma-Aldrich) supplemented with 1× (100 units penicillin and 0.1 mg streptomycin/mL) (Sigma-Aldrich) as well as 10% fetal bovine serum (FBS, Sigma-Aldrich) for N2a and BV2 cells or 15% FBS for C8-D1A cells, all at 37°C and 5% CO 2 . All cells underwent a 24-hour acclimatization period in the electrotactic chamber. N2a cells were first differentiated by serum starvation (0.5% FBS) for an additional 24 hours (Evangelopoulos et al., 2005) before the application of DCEFs. Some cultures of BV2 cells were exposed to 1 μg/mL of lipopolysaccharide (LPS) (Sigma-Aldrich) 24 hours prior to stimulation and their responses compared with non-LPS-activated cells. To control for potential migration of LPS in the electrical field (EF), the concentration of endotoxins was verified using the limulus amoebocyte lysate test (PYROGENT Plus Gel Clot LAL assay, Lonza Walkersville, Inc., Walkersville, MD) following the stimulation period. This confirmed the absence of leakage of LPS outside of the electrotactic chamber (n = 3, P > .05 KruskalWallis; data not shown). C8-D1A cells, which did not undergo further manipulation, were immediately stimulated following the 24-hour acclimatization period. A Nikon Diaphot 300 Phase Contrast Inverted microscope (Mississauga, ON, Canada) with a QICAM digital camera using the QCapture software (QImaging, Surrey, BC, Canada) was used to acquire bright-field photomicrographs, which were used for the morphological analyses. A color filter detecting wavelengths >600 nm (Nikon, Ontario, Canada) was used to identify dead cells stained positively for propidium iodide (15 μM, Invitrogen, Burlington, ON, Canada).
Protein Extraction from Cell Cultures and Western Immunoblotting
Cells were lysed by 5 × 1 second sonication on ice in lysis buffer (50mM Tris 150 mM sodium chloride (NaCl), 1.0% Triton X-100, 0.5% sodium deoxycholate, and 0.5% sodium dodecyl sulfate (SDS), pH 7.4, all from Sigma-Aldrich) supplemented with a complete protease inhibitor cocktail (Roche, Laval, QC, Canada), 10 mg/mL pepstatin A, and the phosphatase inhibitor cocktail 2 (Sigma-Aldrich). Samples were then centrifuged at 13 200 rpm at 4°C for 5 minutes and the supernatant was collected. The protein concentration of each sample was determined using a bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL) according to the manufacturer's protocol. Proteins (10 µg per well) were separated on 8% polyacrylamide SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride membranes (EMD Millipore). Nonspecific binding was blocked with 5% nonfat dry milk and 0.5% bovine serum albumin (BSA) in phosphate buffered saline (PBS)-0.05% Tween 20 for 1 hour. Membranes were probed with the following primary antibodies: cyclooxygenase-2 (COX-2; Cayman Chemical, Ann Arbor, MI), glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Abm, Richmond, BC, Canada), glial derived neurotrophic factor (GDNF; BioVision, Milpitas, CA), growth associated protein-43 (GAP-43; Novus Biological, Littleton, NH), and inducible nitric oxide synthase (iNOS; Sigma-Aldrich), all at dilutions of 1:1000. Blots were incubated with horseradish peroxidase (HRP)-conjugated anti-mouse and anti-rabbit secondary immunoglobulin G antibodies (Jackson ImmunoResearch, West Grove, PA) and visualized by chemiluminescent reagents (Luminata Forte, EMD Millipore). The optical density of each band was quantified using a KODAK Image Station 4000 MM Digital Imaging System and the Molecular Imaging Software (Carestream Health, Rochester, NY).
Cytokine and Chemokine Quantification in the BV2 Culture Media
Following the 24-hour stimulation episode, the culture media of BV2 microglial cells was collected. Floating cells were spun at 1500 rpm and the supernatant was collected and stored at −80°C. Cytokine and chemokine concentrations were quantified using an enzymelinked immunosorbant assay (ELISA)-based chemiluminescent assay, the Q-Plex Mouse cytokine -Screen (16-Plex) (Quansys Biosciences, Logan, UT) following the manufacturer's protocol. The plate was read with a myECL Imager (Thermo Scientific, Whaltam, MA). The concentration of each cytokine was quantified with the Q-View Software (Quansys Biosciences). The following cytokines were detected: interleukin (IL)-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-17, monocyte chemoattractant protein-1 (MCP-1), interferon gamma (IFN-γ), tumor-necrosis factor alpha (TNFα), macrophage inflammatory proteins (MIP), granulocyte-macrophage colony-stimulating factor (GM-CSF), and regulated on activated, normal T cell expressed and secreted (RANTES).
Animals
Male Pitx3-green fluorescent protein (GFP) transgenic mice were housed in our breeding facility and kept in ventilated cages under standard laboratory conditions. These mice express the eGFP reporter under the control of Pitx3. The expression of GFP colocalizes with tyrosine hydroxylase (TH), the enzyme responsible for the ultimate conversion of dopamine, allowing the visualization of dopaminergic neurons in the substantia nigra and VTA (Zhao et al., 2004b) . Mice were mated with CD-1 females overnight, and the presence of a vaginal plug marked gestational day 0.5. Embryos were isolated from pregnant mice at embryonic day 14.5 (E14.5) and the VTA dissected. All animal experiments were performed in accordance with the Canadian Guide for the Care and Use of Laboratory Animals, and all procedures were approved by the Institutional Animal Care Committee of Laval University.
Explant Culture
The VTA of E14.5 Pitx3-GFP heterozygous embryos was isolated in chilled L-15 media (Invitrogen) and dissected into small explants of 450-to 500-μm segments. The explants were cultured in 24-well tissue culture plates (Sarstedt, Montreal, QC, Canada) on 12-mm-diameter coverslips coated with Matrigel (BD Bioscience, Mississauga, ON, Canada). A droplet of Matrigel (approximately 10 μL) was placed over it to form a 3D environment favorable to neurite growth. After gel polymerization, 800 μL of Neurobasal Medium (Invitrogen) with 2% B-27 Serum-Free Supplement (Invitrogen), 1% sodium pyruvate (Invitrogen), 1% l-glutamine (Invitrogen), 1× penicillin and streptomycin (Sigma-Aldrich), and 10% heat-inactivated FBS (Sigma-Aldrich) was added to each well. The explants were incubated at 37°C and 5% CO 2 for 72 hours. After incubation, cultured explants were transferred to the electrotactic chambers for 24 hours of stimulation. Explants were then fixed in 2% paraformaldehyde (J.T. Barker) in PBS, pH 7.4 (Sigma-Aldrich), for 30 minutes, prior to immunofluorescence staining.
Immunofluorescence Staining
Following a 24-hour stimulation session, the PDMS mold forming the electrotactic chamber was removed. N2a, BV2, and C8-D1A cells were fixed for 15 minutes in the petri dish with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 (SigmaAldrich) for phalloidin immunofluorescent staining. Cells or explants were then blocked in 1% BSA (EMD Millipore, Gibbstown, NJ) and stained with 100 units of phalloidin (Invitrogen) for 30 minutes, followed by µg/mL 4',6-diamidino-2-phenylindole (DAPI; Invitrogen). For the microscopic studies, a 60 × 22-mm coverslip was mounted over the cell area with Fluoromount Aqueous Mounting Medium (Sigma-Aldrich), and the bottom of the dish was cut with a rotary tool (Dremel). The explants were blocked and permeabilized with 10% normal goat serum (SigmaAldrich) and 0.1% Triton X-100 in 0.1 M PBS for 1 hour at room temperature. They were subsequently incubated overnight at 4°C with a rabbit anti-TH primary antibody (Pelfreez, Rogers, AR) (1:1000) followed by AlexaFluor-488 conjugated goat anti-rabbit immunoglobulin G (Invitrogen) (1:100) at room temperature for 2 hours. The explants were photographed at 10× magnification using a LSM Pascal confocal microscope (Carl Zeiss Canada Ltd, Toronto, ON, Canada).
Morphological Analyses of Neuronal, Glial Cell Lines, and VTA Explant Cultures
Cellular protrusions from BV2 and C8-D1A cells and neurites from N2a-differentiated neurons as well as orientation of the cell bodies and protrusions were quantified using the Fiji image analysis software (NIH plugin NeuronJ, NIH, Bethesda, MD), as illustrated in Figure 1D . To quantify the effects of the DCEF on protrusion orientation, explants were photographed and acquired images divided into 4 equal quadrants: a quadrant for the cathode, one for the anode, as well as 2 lateral quadrants (Gil and del Rio, 2012) . The length of all neurites was measured on each explant (Fiji image software) for each condition (0 and 50 V/m). The total number and length of TH+ neurites within the cathodal and anodal quadrants were also analyzed.
Statistical Analyses and Image Preparation
All statistical analyses were performed in collaboration with M. Gaétan Daigle from the Service de Consultation Statistique of Université Laval using the SAS software (SAS Institute Inc., Cary, NC), JMP 11.0.0 (SAS Institute Inc.), and Prism 6.0 (GraphPad Software, LaJolla, CA). The graphs were prepared using Prism 6.0 (GraphPad) except for the circular scatterplots, for which we used the Oriana software (Kovach Computing Services, Isle of Anglesey, Wales, UK). All images were prepared for illustration using Adobe Photoshop CS5 and Adobe Illustrator CS5.
Results
DCEF Effects on Viability, Morphology, and Cell Responses
To analyze the effects of DCEFs on neuronal-like cells, differentiated N2a cells were exposed to 0, 25, 50, and 100 V/m DC stimulation for 24 hours (Figure 2 ). None of these experimental conditions (25, 50, 100 V/m) induced significant cell death as revealed by propidium iodide staining (Figure 2A ), nor did the various DCEFs affect the percentage of neuronal cells with neurite outgrowth which was used as a sign of cell differentiation (Evangelopoulos et al., 2005) (Figure 2B ). However, the neurites were longer in all experimental conditions and this correlated with DCEF intensity ( Figure 2D , H-K; Table 1 ). In addition, DCEF influenced the orientation of the neurites towards the cathode ( Figure 2E , H-K); the greater the intensity of the EF applied, the more the neurites aligned in the direction of the cathode. Corroborating these morphological changes, the application of 25 or 50 V/m DCEF increased cellular levels of GAP-43 ( Figure 2C ), a protein largely expressed in growth cones (Biewenga et al., 1996) .
In addition to altering neurite properties, DCEFs had a direct effect on the cell body of differentiated N2a cells. The length of the cell body was significantly increased with 25 and 50 V/m stimulation but not at 100 V/m or in the absence of stimulation ( Figure 2F ). Cell bodies also responded to DCEFs by changing their orientation such that they aligned themselves parallel to the EF ( Figure 2G , scatterplots).
DCEF Effects on Dopaminergic Explants
To test the effects of DCEFs on specific cell populations such as dopaminergic neurons, we used VTA explants derived from embryos of Pitx3-GFP mice. After a 24-hour stimulation with 50 V/m DCEF, virtually all TH+ neurites grew towards the cathode ( Figure 3A-C) . However, the 50 V/m DCEF did not change the number of neurites (data not shown), which was significantly lower in the direction of the anode compared with the cathode ( Figure 3D ).
DCEF Effects on Viability, Morphology, and Microglial Cell Responses
We next assessed the impact of 0 to 100 V/m DCEF on microglial cells using the BV2 murine cell line. To reproduce the hallmark of a cerebral inflammatory response, BV2 cells were analyzed both in a resting and LPS-activated state (Figure 4) . Although the viability of resting microglial cells was slightly different between DCEFs conditions, it was not significantly different from the control condition ( Figure 4A ). Cells demonstrated better viability following exposure to 50 V/m than to 25 and 100 V/m DCEFs. However, the viability of LPS-activated BV2 cells significantly decreased with increasing intensity of the DCEFs (Table 1) .
When quiescent BV2 cells were stimulated, a higher percentage of cells with protrusions was observed at 25 and 50 V/m compared with the control and 100 V/m condition ( Figure 4B , G-J), an effect that followed a second-order polynomial regression, meaning that cells show a peak response at 50 V/m but with similar reactions at 0 and 100 V/m (Table 1) . A similar pattern was observed for the length of the protrusions ( Figure 4C , G-J). However, when LPS-activated microglial cells were stimulated, the percentage of BV2 cells with protrusions, as well as the length of these protrusions, was significantly reduced in all experimental conditions when compared with control. These reductions negatively correlated with DCEF intensity ( Figure 4B -C, K-N; Table 1 ). The length of the protrusions was significantly higher in LPS-activated compared with quiescent cells under 0, 25, and 100 V/m stimulation ( Figure 4C ). The pattern of protrusion orientation in LPS-activated cells revealed an even distribution of protrusions in the DCEF with no preferred direction of growth. However, at a 100V/m stimulation of resting cells, there was a reorientation of the protrusions so that they were parallel to the DCEF ( Figure 4D ). Although changes in cell body length were not observed in quiescent cells, there was a reduction in cell body length in LPS-activated cells in all experimental conditions compared with control, with the most striking effect at 100 V/m ( Figure 4E ). In control conditions (0 V/m), the length of the cell body was significantly increased in LPS-activated compared with quiescent BV2 cells. Only in resting conditions were cell bodies depicting a significant orientation shift, which was parallel to the EF and was also seen with 50 V/m and 100 V/m DCEFs ( Figure 4F ).
To further study the impact of DCEFs on microglial cells, we quantified cytokine secretion and expression levels of COX-2 (Alhouayek and Muccioli, 2014) and iNOS (Vejlstrup et al., 1998) (Figure 5 ). Using ELISA assays, we found that cytokine levels secreted in culture media were similar in all conditions (Table 2 ) and that the concentration of iNOS was not modified by DCEF ( Figure 5B ). However, in resting BV2 cells, a 100V/m stimulation induced a significant increase in COX-2 protein levels ( Figure 5A ).
DCEF Effects on Viability, Morphology, and Astrocyte Responses
The cell viability ( Figure 6A ) and percentage of astrocytes developing protrusions ( Figure 6B ) were similar in all experimental conditions. C8-D1A cells were characterized by elongated protrusions in all experimental conditions when compared with the control setting ( Figure 6C , G-J). The orientation of the protrusions was uniform for all conditions except at 100 V/m, where they were reoriented perpendicularly to the DCEF ( Figure 6D ). The cell body length was increased with DCEF intensity and followed a linear regression ( Figure 6E , G-J; Table 1 ). Cell bodies also oriented themselves, so that they were perpendicular to the DCEF, with an increasing number pointing in the same direction with increasing DCEF intensity ( Figure 6F ). Despite the morphological changes observed in astrocytes, we failed to detect significant changes in glial derived neurotrophic factor protein levels (n = 2; data not shown).
Discussion
Weak extracellular DCEFs can alter the migration, shape the morphology, and influence the growth and metabolism of a number of cell types (for review; Pelletier and Cicchetti, 2014 and see Table 3 ). In this study, we built on these observations and now further report on the viability, morphological phenotypes, and various responses in the major cell types of the central nervous system: neurons and glial cells (Table 4) .
For this particular study, we chose to work with immortalized cell lines because of their homogeneity and reproducibility in vitro. We thus selected 3 commonly used cell lines. The N2a cells (N2a murine neuroblastoma cells) have been widely used to study a variety of cellular processes (Jacobsson and Fowler, 2001 ; Alais et al., 2008; Wang et al., 2011) . BV2 cells are used in vitro as a model of microglia, because they have been shown to respond to pharmacological agents and demonstrate normal microglial function, such as phagocytosis. Compared with primary microglia, the BV2 cells have similar cell activation patterns to LPS stimulation, including the activation of inflammation-related kinases (JNK and p-38) and transcription factors (nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and c-Jun) as well as the release of inflammatory mediators (eg, TNFα, IL-1β, and nitroc oxide (NO)) (Henn et al., 2009 ). Finally, we used the type-1 astrocyte cell line (C8-D1A cells, ATCC), which expresses GFAP and displays the classic morphology of these cells (Booth and Kim, 2012) .
We first demonstrated that the viability and number of N2a murine cells differentiated into neurons were not affected by DCEFs. The cells responded to DCEFs, as shown by their neurite outgrowth and their alignment in the EF. Although this neurite outgrowth effect of DCEF in N2a cells has been observed (Jain et al., 2013) , there have been no previous reports on their alignment in the EF (Table 3 ). The elongation of neuronal processes towards the cathode is a phenomenon, however, now widely recognized. It is hypothesized to be caused by changes in the gating of Ca 2+ at the growth cone of the neurite and by the electrophoretic or electroosmostic movements of membrane receptors (Borgens et al., 1994; McCaig et al., 2005) . The reorganization of the cytoskeleton has also been suggested to play a role (Zhao et al., 2004) .
Supplementing these observations, we described that cell bodies repositioned their orientation in the EFs. We also found an increase in GAP-43 levels, a protein expressed in neuronal growth cones during synaptogenesis and axonal development/ regeneration (Biewenga et al., 1996) , although neurite length, which corresponds to overall growth, and the expression of GAP-43 did not follow a linear pattern. In other words, GAP-43 expression did not augment with neurite length at 50-V/m stimulation or higher. Despite the fact that GAP-43 has been reported to correlate with axonal/neurite elongation (Meiri et al., 1986; Biffo et al., 1990; Benowitz and Routtenberg, 1997) , it has also been described to be absent in dendrites of hippocampal neurons in culture (Goslin et al., 1988) and is not necessary for PC12 neurite outgrowth (Baetge and Hammang, 1991) . Alternatively, GAP-43 has been associated with axonal sprouting (Aigner et al., 1995; Buffo et al., 1997) , which indicates a potential involvement in neurite sprouting rather than elongation. Taken together, our results nevertheless support the increase in GAP-43 levels previously measured after anodal tDCS in ischemic rodent brains (Yoon et al., 2012) . To further explore the effects of DCEF on neuronal populations, we applied DCEF to VTA explants from Pitx-3-GFP mice, allowing the visualization of dopaminergic neurons, a cell population that would be of particular interest in the treatment of Parkinson's disease with tDCS. With a stimulation of 50 V/m, we observed that the dopaminergic neurites reoriented towards the negative pole of the EF, the cathode.
We next examined the impact of DCEFs on microglia. BV2 microglial cells can rapidly change their morphology in response to environmental cues, showing a highly ramified phenotype (Sheng et al., 2011) and transiting from an inactivated amoeboid to an elongated shape (Michaud et al., 2013) . The activation of microglial cells also induces a dramatic change in protein expression (eg, proinflammatory cytokines). The expression of COX-2 and iNOS, respectively responsible for the synthesis of prostaglandin E2 (PGE2) and NO, are increased when microglia are activated. They both have been identified as drug targets to dampen the inflammatory response and thus potentially impact the neurodegenerative processes (del Zoppo et al., 2000; Knott et al., 2000; Teismann et al., 2003; Yu et al., 2004; Mollace et al., 2005) . In our hands, DCEFs had an effect on COX-2 expression, but not iNOS levels, in quiescent BV2 cells when using higher voltages (100 V/m), which reflect the fact that the expression kinetic between these molecules may not always follow identical patterns. For example, in fibroblasts, LPS-induced COX-2 secretion was stable between 24 and 48 hours after LPS activation, while the production of iNOS peaked at 24 hours and decreased afterwards (Zhu et al., 2012) . Furthermore, we did not observe changes in the concentration of extracellular cytokines in any of the conditions tested. As a whole, our results show that DCEFs can impact microglial cell morphology without significantly modulating their responses, at least not under the conditions that we tested. Observations of DCEF effects on microglial cells have not been reported previously (Table 3) . However, several pathologies for which DCEFs could be used are characterized by a significant neuroinflammatory response, and our current knowledge of the type and magnitude of the neuroinflammatory reaction triggered or suppressed by DCEFs is very limited. In vitro evidence suggests that DCEFs can polarize and accelerate the migration of various types of peripheral immune cells, including lymphocytes (Li et al., 2011) , monocytes (Lin et al., 2008) and neutrophils (Zhao et al., 2006) , macrophages (Orida and Feldman, 1982) , and polymorphonuclear cells (Franke and Gruler, 1990) , but there has been no account of measurable functional changes. In rodents, high intensity (≥142.9 A/m 2 ) unilateral cathodal tDCS of the parietal cortex induces tissue damage (Liebetanz et al., 2009) , whereas both unilateral cathodal and anodal tDCS of the motor cortex increases the number of microglia cells (ionized calcium-binding adapter molecule 1 (Iba1) + ) in stimulated structures (Rueger et al., 2012) . At lower intensity (33.4 A/m 2 ), bilateral anodal tDCS over the parietal cortex lowers hippocampal TNFα protein levels in a rat model of chronic stress-induced pain (Spezia Adachi et al., 2012) . In mice stimulated with cathodal tDCS (55.0 A/m 2 ) following middle cerebral artery occlusion, Iba1 + and CD45 + cells are reduced in the ischemic cortex hours following stimulation of the damaged area (Peruzzotti-Jametti et al., 2013) . These data support the concept that DCEF can have an effect on the behavior of microglial cells. Whether this response results from stimulation parameters or complex cell interactions, or both, will require further investigation.
Not surprisingly, astrocytes also react to DCEFs. It is known that DCEFs can align astrocytes perpendicular to the EF both in vitro (Borgens et al., 1994; Alexander et al., 2006) and in vivo (Moriarty and Borgens, 2001 ). In addition to confirming this effect in vitro, we demonstrated that protrusions and cell body length are affected by DCEFs and that they both reorient in a similar manner (Table 3) . Previous studies have suggested that neurites realign according to the astrocyte position. In other words, the direction adopted by astrocytes dictates the direction of the growing neurites (Alexander et al., 2006) . Despite these preliminary observations, the role of astrocytes in DCEF therapy is largely unknown. Interestingly, recent work on DBS argues that the induction of a significant astrocytic response actually enhances its effects (Fenoy et al., 2014) , with the suggestion that the inevitable stimulation of astrocytes by DBS can set in motion the release of gliotransmitters that can in turn trigger axonal activation, which mediates part of the therapeutic benefits observed. Astrocytes, which can interact with more than 2 million synapses in the human brain, can thereby have a profound effect on synaptic activity across large neural networks (Oberheim et al., 2006; Cicchetti and Barker, 2014) , and something similar may happen with tDCS. The complexity of cellular interactions and their impact on the observations we have made is certainly not fully accounted for in the in vitro setting. Future work using co-culture systems would be a first step in attempting to understand the impact of one cell response to DECF on another.
The approach of tDCS is currently the most common therapy to use DCEF, although its mechanisms of action are still poorly understood (for review, see Pelletier and Cicchetti, 2014) . In vitro and in vivo animal studies conducted thus far are rare, and the parameters used (duration and intensity of stimulation) are so diverse from one study to the other that it is hard to interpret the data in the clinical setting. The DCEF parameters (25-100 V/m) chosen for our study are very similar to the bulk of studies published in vitro and in vivo (Bikson et al., 2004; Kabakov et al., 2012) . These intensities are admittedly higher than what is typically used in human tDCS, where stimulation amounts to ≤1 V/m, for a maximum of 0.28 A/m 2 brain current Abbreviations: GMCSF, granulocyte-macrophage colony-stimulating factor; IL, interleukin; IFNγ, interferon gamma; LPS, lipopolysaccharide; RANTES, regulated on activated, normal T cell expressed and secreted; SD, standard deviation; TNFα, tumor-necrosis factor alpha. (Minhas et al., 2012) . In animal studies, brain current density has reached up to 142.0 A/m 2 . DCEF-induced cellular responses have been consistently demonstrated to be dependent on the length (Bedlack et al., 1992; Erskine et al., 1995; Zhao et al., 2004a; Rajnicek et al., 2006a Rajnicek et al., 2006b ) and intensity of the EF applied (Li and Kolega, 2002; Bai et al., 2004; Rajnicek et al., 2006a Rajnicek et al., 2006b . It is thus likely that tDCS in humans, which is delivered over relatively short periods of time and at weaker intensities, leads to more subtle modulations than those reported in our study. However, the effects observed with tDCS could originate from an impact on the plasticity of existing synapses, as this response is much quicker than actual morphological changes. In vitro brain slices as well as animal and human experiments have all provided evidence that tDCS affects neurotransmitter release (for review, see Pelletier and Cicchetti, 2014) . However, morphological changes induced by DCEFs have, thus far, been reported only in monolayer cultures or a guinea pig model of spinal cord injury (Borgens, 1999; Moriarty and Borgens, 2001) . In this particular case, which used stimulation intensity lower than those used in human tDCS but for longer duration (Nitsche et al., 2008) , both axon and astrocyte morphology demonstrated significant changes as observed in vitro. This not only supports the observations reported in our study as well as in other experiments using monolayer cultures reduced; ↑, increased; −, no response; All, all conditions; COX-2, cyclooxygenase-2; DA, dopamine; EF, electric field; GAP-43, growth-associated protein-43; GDNF, glial derived neurotrophic factor; iNOS, inducible nitric oxide synthase; LPS, lipopolysaccharide; NT, not tested; ⊥, perpendicular; �, parallel; V/m, Volt/meter. (Patel and Poo, 1982; Borgens et al., 1994) but also suggests that similar changes could occur in human tDCS. Furthermore, the increase of GAP-43 and microtubule associated protein-2 (MAP-2) (Yoon et al., 2012) after 5 × 20-minute tDCS sessions (28.2 A/m 2 ) in rats provides evidence that axonal morphology can be modified using stimulation periods as short as those utilized in humans. The relevance of tDCS parameters used in animal experiments further finds support in the behavioral outcomes that have been reported to be similar in several animal models of disease (eg, improvements of motor features in Parkinson's disease patients and a rat model of the disease and anticonvulsive properties in epileptic patients as in a rat model of epilepsy). This has been extensively discussed in Pelletier and Cicchetti (2014) .
This disparity between human, animal, and in vitro tDCS parameters does not necessarily invalidate the results obtained in animals nor in in vitro studies, as the latter setting offers a number of advantages over more complex systems. Electric current direction and intensity can easily be manipulated in in vitro models , which may in turn facilitate the understanding of cellular and molecular mechanisms involved in this approach. Nevertheless, data interpretation in vitro should be made with caution and ultimately confirmed in vivo. Importantly, stimulation parameters in humans are still largely unexplored, and optimal conditions have yet to be identified. The tolerability and safety of higher current densities, which may be more desirable in acute disease contexts, remain to be tested (Nitsche et al., 2008) .
Conclusion
Using an in-house DCEF prototype on 3 representative cell types of the central nervous system, our study provides evidence that cells respond to EFs, as shown by changes in their morphology, elongation, and retraction of their neurites/protrusions with some changes in their molecular responses. Despite the fact that tDCS is still at an early stage of clinical application, the in vitro and in vivo observations to date are encouraging and warrant further investigation. This will allow for a better understanding of how the therapy may work and, with this, the ability to better use it with greater effect in patients suffering from various brain disorders.
